Today: 20 May 2026
Browse Category

NASDAQ:CRDO 14 December 2025 - 5 March 2026

Credo Technology Group Holding stock jumps as Broadcom backs copper over optics in AI racks

Credo Technology Group Holding stock jumps as Broadcom backs copper over optics in AI racks

Credo Technology shares climbed 9% to $111.94 Thursday after Broadcom endorsed copper-linked wiring for AI data centers. The gain followed a 14.8% drop earlier in the week on lower gross-margin guidance despite record quarterly revenue of $407 million, up 201.5% year over year. Credo’s top three customers grew sequentially, but together made up 88% of revenue, heightening concentration risk.
5 March 2026
··
Credo Technology stock slides 14% after record quarter as margin outlook draws focus

Credo Technology stock slides 14% after record quarter as margin outlook draws focus

Credo Technology shares dropped 14.3% to $97.87 after the company forecast lower gross margins of 63.9% to 65.9% for the current quarter, down from 68.5%. Fiscal third-quarter revenue hit a record $407 million, with current-quarter guidance at $425 million to $435 million. Credo ended the quarter with $1.3 billion in cash and acquired connectivity IP provider CoMira Solutions.
3 March 2026
···
Credo (CRDO) stock drops 13% premarket after earnings: margin outlook, CoMira deal in focus

Credo (CRDO) stock drops 13% premarket after earnings: margin outlook, CoMira deal in focus

Credo Technology shares fell 13% premarket Tuesday after the company forecast lower gross margins for the current quarter. Fiscal Q3 revenue reached $407 million, with net income at $157.1 million. Credo projected Q4 revenue of $425–$435 million and acquired CoMira Solutions to expand its semiconductor IP portfolio. Three customers each accounted for over 10% of quarterly revenue, with the largest at 39%.
3 March 2026
··
Credo Technology stock jumps again in premarket after surprise revenue lift

Credo Technology stock jumps again in premarket after surprise revenue lift

Credo shares jumped 16.6% to $143.88 in premarket trading after the company projected fiscal Q3 revenue of $404 million to $408 million, well above prior guidance. The company flagged over 200% revenue growth for fiscal 2026 and expects mid-single-digit sequential growth into Q4. Full results are due March 2. The revenue figures are preliminary and unaudited.
10 February 2026
···
Credo Technology stock rebounds today as AI-chip jitters ease; what’s next for CRDO

Credo Technology stock rebounds today as AI-chip jitters ease; what’s next for CRDO

Credo Technology shares rose about 2% to $98.96 Thursday afternoon, rebounding after recent losses. A Bank of America note challenged the AI-chip selloff, citing sector bottlenecks. Insider-sale filings and a March earnings report kept traders cautious. Roughly 5.8 million shares traded as Credo’s market cap neared $32.5 billion.
5 February 2026
····
Credo Technology (CRDO) stock climbs as AI-chip trade stays hot; Needham conference next

Credo Technology (CRDO) stock climbs as AI-chip trade stays hot; Needham conference next

Credo Technology shares rose 3.1% to $155.10 Monday, trading as high as $156.43 amid sector gains and anticipation of its Jan. 14 presentation at Needham’s Growth Conference. The company last reported $268 million in quarterly revenue and forecast up to $345 million for the next period. TSMC will report earnings Jan. 15, with investors watching for AI chip demand signals.
12 January 2026
···
Credo (CRDO) stock jumps 6% after-hours after insider filings; Needham conference is next focus

Credo (CRDO) stock jumps 6% after-hours after insider filings; Needham conference is next focus

Credo Technology shares climbed about 6% to $141 in after-hours trading Wednesday, following a volatile regular session. SEC filings showed executives had shares withheld to cover taxes on vested stock awards. Nearly 10 million shares traded, 27% above average volume. CEO Bill Brennan and CFO Dan Fleming are scheduled to present at Needham’s Growth Conference in New York on Jan. 14.
8 January 2026
·
Credo stock slips as chip ETFs jump; Form 144 filing draws focus

Credo stock slips as chip ETFs jump; Form 144 filing draws focus

Credo Technology shares fell 0.47% to $143.22 Friday, underperforming semiconductor peers as the iShares Semiconductor ETF rose 4.2%. A Form 144 filing dated Jan. 2 appeared on the company’s investor site, signaling possible insider sales. About 5.8 million shares traded in a range between $141 and $152. Investors await next week’s U.S. payrolls report and Credo’s next earnings in early March.
3 January 2026
···
Credo Technology Group (CRDO) Stock: What to Know Before the Market Opens on Dec. 26, 2025

Credo Technology Group (CRDO) Stock: What to Know Before the Market Opens on Dec. 26, 2025

Credo Technology Group (CRDO) last traded at $150.19 on Dec. 24, ahead of a post-Christmas session expected to see thin liquidity and sharp price swings. The stock surged after reporting Q2 FY2026 revenue of $268 million, up 20% from the prior quarter, and guiding Q3 revenue to $335–$345 million. Management cited demand from AI infrastructure buildouts. Gross margin guidance for Q3 is lower than Q2.
26 December 2025
·
Credo Technology (CRDO) Stock After the Bell on Dec. 24, 2025: What to Know Before the Next Market Open

Credo Technology (CRDO) Stock After the Bell on Dec. 24, 2025: What to Know Before the Next Market Open

Credo Technology Group (CRDO) closed Dec. 24, 2025, at $150.19, up 1.61% on light volume during the holiday-shortened session. After-hours trading showed a slight uptick to $150.37. U.S. markets were closed Dec. 25 for Christmas, with the next full session set for Dec. 26. Broader indexes, including the Dow and S&P 500, ended at record highs amid thin holiday trading.
25 December 2025
··
Credo Technology Group (CRDO) Stock: Latest News, Analyst Price Targets, and 2026 Outlook as AI Data-Center Demand Stays Hot (Dec. 15, 2025)

Credo Technology Group (CRDO) Stock: Latest News, Analyst Price Targets, and 2026 Outlook as AI Data-Center Demand Stays Hot (Dec. 15, 2025)

Credo Technology Group shares traded at $144.31 on December 15, 2025, giving the company a market cap near $32.5 billion and a P/E ratio of about 153. Institutional filings showed Liontrust and Castleark cut their CRDO holdings in Q2 after major gains. The stock’s surge followed record Q2 FY2026 results, with revenue up 272% year over year to $268 million.
15 December 2025
····
Credo Technology (CRDO) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025

Credo Technology (CRDO) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025

Credo Technology Group shares fell 6.8% Friday to $143.91, capping a five-day drop of about 20% despite record quarterly results and strong guidance. The stock remains 33% below its 52-week high of $213.80. Q2 revenue jumped 272% year-over-year to $268 million, with non-GAAP EPS at $0.67. Management cited demand from AI data centers and forecast Q3 revenue of $335–$345 million.
14 December 2025
·
1 2 3

Stock Market Today

  • Jim Cramer Cautions on Nvidia Earnings Impact: Possible Initial Jump Followed by Decline
    May 20, 2026, 9:53 AM EDT. Jim Cramer warned investors that Nvidia's upcoming earnings could trigger an initial surge in NVDA stock price, followed by a sharp decline, despite potentially strong financial results. Cramer suggested that Wall Street's high expectations might lead to a 'relentless hammering' post-earnings, reflecting concerns over valuation and market sentiment. Nvidia remains a key player in the chipmaking sector, with its stock volatility closely watched by investors amid growing interest in AI and data center technologies.

Latest articles

TJX Stock Jumps Before the Bell After T.J. Maxx Owner Lifts Profit View

TJX Stock Jumps Before the Bell After T.J. Maxx Owner Lifts Profit View

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
AmpliTech Jumps After 5G Approval Clears North America Sales Path

AmpliTech Jumps After 5G Approval Clears North America Sales Path

20 May 2026
AmpliTech received U.S. and Canadian certification for its full indoor 5G Native DAS hardware, enabling immediate commercial sales and integration across North America. Shares rose about 14% in premarket trading after the announcement. The company said it has orders from a North American mobile network operator, with shipments set to begin later this year.
Go toTop